News | Magnetic Resonance Imaging (MRI) | February 17, 2021

New study shows there is a lot to consider

T1 structural images for the two sequences, MPRAGE and MPRAGE+PMC. The top row shows the MPRAGE sequence, while the bottom row shows the images that were generated with the MPRAGE+PMC sequence. Columns represent two different participants, one with minimal head motion (left, Low-Mover) and another with a large quantity of motion (right, High-Mover). Pial and white matter (WM) surface reconstruction from Freesurfer are also shown.

T1 structural images for the two sequences, MPRAGE and MPRAGE+PMC. The top row shows the MPRAGE sequence, while the bottom row shows the images that were generated with the MPRAGE+PMC sequence. Columns represent two different participants, one with minimal head motion (left, Low-Mover) and another with a large quantity of motion (right, High-Mover). Pial and white matter (WM) surface reconstruction from Freesurfer are also shown.


February 17, 2021 — A new paper, "Is it time to switch your T1W sequence? Assessing the impact of prospective motion correction on the reliability and quality of structural imaging," evaluates two different ways of collecting magnetic resonance imaging (MRI) structural images. The first type of sequence, called MPRAGE, has been widely used by the neuroimaging research community for the last 20-plus years. More recently, an updated version of this sequence that includes Prospective Motion Correction (PMC) has been developed. The sequence with PMC adapts the MPRAGE sequence based on participant head motion. That makes it ideal for collecting data on children, who often struggle to hold still during MRIs. However, researchers are reluctant to change MRI sequences, since that typically means that they will not be able to use old and new data together in a statistical analysis.

"That's where this study comes in," said Alexandre Franco, Computational Neuroimaging Laboratories Director at The Nathan S. Kline Institute for Psychiatric Research and a research scientist at the Child Mind Institute. "It directly compares the reliability of the two sequences, MPRAGE and MPRAGE+PMC."

By using data collected for a Healthy Brain Network initiative that performed two MPRAGE and two MPRAGE+PMC sequences within the same imaging session, with one MPRAGE (MPRAGE1) and MPRAGE+PMC (MPRAGE+PMC1) pair at the beginning of the session and another pair (MPRAGE2 and MPRAGE+PMC2) at the end of the session, the new study directly compares two sequences from 348 participants. The study aimed to determine if the morphometric measurements obtained from both protocols are equivalent or if one sequence has a clear advantage over the other, while also comparing them through other quality control measurements. Results show that there is a high inter-sequence reliability between the MPRAGE and MPRAGE+PMC sequences. Results also indicate that the MPRAGE+PMC sequence is robust, but not impervious, to high head motion. "In the end use we suggest that studies targeting hyperkinetic populations use the MPRAGE+PMC sequence, given its higher robustness to head motion and higher reliability scores," said Franco.

For more information: www.childmind.org


Related Content

News | Digital Pathology

March 11, 2026 — Royal Philips has announced the expansion of its digital pathology portfolio with new cloud-enabled ...

Time March 26, 2026
arrow
News | Radiology Business

March 1, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that practice turnover (i.e ...

Time March 19, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
News | Enterprise Imaging

Mar. 9, 2026 — GE HealthCare recently announced that View, the viewer within the Genesis Radiology Workspace, has ...

Time March 12, 2026
arrow
News | FDA

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiology Business

March 5, 2026 — Cassling is now accepting applications for the 2026 Imaging for Impact Award, a national recognition ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
Subscribe Now